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The carcinogenicity of TCDD has long been established in experimental animals, and an extensive literature exists addressing mechanistic aspects relevant to the carcinogenic process. In animals TCDD, the most potent dioxins congener, is a multisite carcinogen that induces cancer in different organs, species and strains. The association between exposure to TCDD and cancer in humans has been investigated in different subsets of populations including Vietnam veterans, occupationally exposed workers and the cohort of residents in the accidentally contaminated area of Seveso, Italy.
In 1997, the International Agency for Research on Cancer (IARC) classified TCDD as a group 1 carcinogen based on limited evidence in humans, sufficient evidence in animals and mechanistic data indicating the involvement of the Ah receptor present in both humans and animals. The IARC evaluation was mainly based on four highly exposed industrial cohorts with a well characterized exposure, and on the Seveso cohort results. The strongest evidence was seen for all cancers which showed an increased risk in all four industrial cohort. A positive exposureresponse was observed in two of them. Results by specific cancer sites were less consistent. Noteworthy were the increased risks for lung cancer and Non-Hodgkin’s lymphoma in the highly exposed subcohorts.
Since the IARC evaluation, new data have been published that seem to strengthen the previous evaluation. In particular, further dose-response analyses have been performed in three industrial cohorts (NIOSH, Dutch and Germany cohorts) showing a positive trend for all cancers and a meta-analysis of these same cohorts confirmed a positive and significant trend. The mortality of the Seveso cohort showed increases for all cancers (RR=1.3; 95%CI 1.0-1.7) and lung cancer (RR= 1.3, 95%CI 1.0-1.7) after a longer than 15 years period of follow-up, among men residing in the highly exposed zones (A and B). Lymphopoietic neoplasms were consistently increased in males (RR=1.7, 95%CI 1.0-2.8) and females (RR=1.8, 95% CI 1.1-3.2) in those same zones.
Although based on a limited number of cases, the Seveso Women Health Study found a positive relationship between TCDD serum level and breast cancer incidence.
Overall, the evidence accrued in recent years confirms the 1997 IARC evaluation of dioxin as a human carcinogen.

